The prevalence of Chlamydia pneumoniae in atherosclerotic and nonatherosclerotic blood vessels of patients attending for redo and first time coronary artery bypass graft surgery

Journal of the American College of Cardiology

Volumn 33, Issue 1, 1999, Pages 152-156

  Wong, Yuk K I ^a,b   Thomas, Martine ^a   Tsang, Victor ^a,b   Gallagher, Patrick J ^c   Ward, Michael E ^b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DISEASE ASSOCIATION; ENDARTERECTOMY; FEMALE; GRAFT FAILURE; HUMAN; HUMAN TISSUE; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL;

AGED; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; CORONARY VESSELS; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; MALE; MAMMARY ARTERIES; MIDDLE AGED; RECURRENCE; REOPERATION; RISK FACTORS; SAPHENOUS VEIN;

EID: 0032922089     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00547-6     Document Type: Article

References (32)

1. Saikku P, Mattila K, Nieminen MS, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart-disease and acute myocardial-infarction. Lancet 1988;2:983-6.
2. Saikku P, Leinonen M, Tankanen L, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart-disease in the Helsinki Heart-Study. Ann Intern Med 1992;116:273-8.
3. Patel P, Mendall MA, Carrington D, et al. Association of Helicobacter-pylori and Chlamydia pneumoniae infections with coronary heart-disease and cardiovascular risk-factors. BMJ 1995;311:711-4.
4. Thorn DH, Grayston JT, Siscovick DS, Wang SP, Weiss NS, Daling JR. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary-artery disease. JAMA 1992;268:68-72.
5. Kark JD, Leionen M, Paltiel O, Saikku P. Chlamydia pneumoniae and acute myocardial infarction in Jerusalem. Int J Epidemiol 1997;26:730-8.
6. Short A, Kuo CC, Patton DL. Detection of chlamydia-pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J 1992;82:158-61.
7. Maass M, Bartels C, Engel PM, Mamat U, Sievers HH. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol 1988;31:827-32.
8. Muhlestein JB, Hammond EH, Carlquist JF, et al. Increased incidence of Chlamydia species within the coronary-arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular-disease. J Am Coll Cardiol 1996;27:1555-61.
9. Ramirez JA, Ahkee S, Summersgill JT, et al. Isolation of Chlamydia pneumoniae from the coronary-artery of a patient with coronary atherosclerosis. Ann Intern Med 1996;125:979-82.
10. Ong G, Thomas BJ, Mansfield AO, Davidson BR, TaylorRobinson D. Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J Clin Pathol 1996;49:102-6.
11. Kuo CC, Grayston JT, Campbell LA, Goo YA, Wissler RW, Benditt EP. Chlamydia pneumoniae (TWAR) in coronary-arteries of young adults (15-34 years old). Proc Natl Acad Sci USA 1995;92:6911-4.
12. Campbell LS, Obrien ER, Cappuccio AL, et al. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis 1995;172:585-8.
13. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997;350:430-6.
14. Nwasokwa ON. Coronary Artery Bypass Graft Disease. Ann Intern Med 1995;123:528-45.
15. Cunningham A, Johnson S, Julious S, Sillis M, Ward ME. The role of Chlamydia pneumoniae and other pathogens in acute episodes of asthma in children. In: Orfila J, Byrne GI, Chernesky MA, et al. (eds.) Proceedings of the 8th International Symposium on Human Chlamydial Infections. Bologna: Società Editrice Esculapio, 1994:480-3.
16. Jackson LA, Campbell LA, Kuo CC, Rodriguez DI, Lee A, Grayston JT. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis 1997;176:292-5.
17. Kuo CC, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JT. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993;167:841-9.
18. Hammond EH, Muhlestein JB, Hammond TH, Carlquist JF, Anderson JL. High incidence of Chlamydia pneumoniae in atherosclerosis of coronary arteries with both genus and species specific antisera [abstract]. JACC 1998;31:A146.
19. Juvonen JJ, Tuvonen T, Laurila A, et al. Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms. J Vase Surg 1997;25:499-505.
20. Chiu B, Viira E, Tucker W, Fong IW. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation 1997;96:2144-8.
21. Lindholt JS, Ostergard L, Henneberg EW, Fasting H, Andersen P. Failure to demonstrate Chlamydia pneumoniae in symptomatic abdominal aortic aneurysms by a nested polymerase chain reaction (PCR). Eur J Vase Endovasc Surg 1998;15:161-4.
22. TaylorRobinson D, Ong G, Thomas BJ, Rose ML, Yacoub MH. Chlamydia pneumoniae in vascular tissue from heart-transplant donors [letter]. Lancet 1988;351:1255.
23. Jackson LA, Campbell LA, Schmidt RA, et al. Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma-Evaluation of the innocent bystander hypothesis. Am J Pathol 1997;150:1785-90.
24. Gottsaunerwolf M, Moliterno DJ, Lincoff AM, Topol EJ. Restenosis - an open file. Clin Cardiol 1996;19:347-56.
25. Muhlestein JB, Anderson JL, Hammond EH, et al. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 1998;97:633-6.
26. Fong IW, Chiu B, Viira E, Fong MW, Jang D, Mahony J. Rabbit model for Chlamydia pneumoniae infection. J Clin Microbiol 1997;35:48-52.
27. Laitinen K, Laurila A, Pyhala L, Leinonen M, Saikku P. Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits. Infect Immun 1997;65:4832-5.
28. Moazed TC, Kuo CC, Patton DL, Grayston JT, Campbell LA. Experimental rabbit models of Chlamydia pneumoniae infection. Am J Pathol 1996;148:667-76.
29. Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 1997;96:404-7.
30. Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. Lancet 1997;350:404-7.
31. ACADEMIC (azithromycin in coronary artery disease: Elimination of myocardial infection with Chlamydia). Clin Cardiol 1998;21:429-30.
32. Sinisalo J, Mattila K, Nieminen MS, et al. The effect of prolonged doxycycline therapy on Chlamydia pneumoniae serological markers, coronary heart disease risk factors and forearm basal nitric oxide production. J Antimicrob Chemother 1998;41:85-92.